Medical Device Investing News

Medical Device Investing

Abiomed Announces Peripartum and Postpartum Cardiomyopathy Approval

Medical Device Investing

Abiomed (NASDAQ:ABMD), a leading provider of breakthrough heart support and recovery technologies, announced today the launch of a new indication and Women’s Initiative focused on heart recovery education and awareness. As quoted in the press release: According to the Centers for Disease Control and Prevention (CDC), cardiovascular disease is the number one killer of women …

Abiomed (NASDAQ:ABMD), a leading provider of breakthrough heart support and recovery technologies, announced today the launch of a new indication and Women’s Initiative focused on heart recovery education and awareness.

As quoted in the press release:

According to the Centers for Disease Control and Prevention (CDC), cardiovascular disease is the number one killer of women and causes 35% of deaths (approximately 430,000) in American women over the age of 201. Two causes of death as a result of cardiogenic shock, specific to the female population are PPCM and spontaneous coronary artery dissection (SCAD).

Click here to read the full press release.

cardiovascularcdcdiseasewomenMedical Device Investing

MARKETS

Markets
TSX19062.91+345.79
TSXV647.33+15.54
DOW31500.68+823.32
S&P 5003911.74+116.01
NASD11607.62+375.43
ASX6528.40+19.90

COMMODITIES

Commodities
Gold1827.54+0.47
Silver21.15+0.03
Copper3.740.00
Palladium1879.51+6.50
Platinum911.26+4.32
Oil107.06+2.79
Heating Oil4.24+0.02
Natural Gas6.17-0.07

DOWNLOAD FREE REPORTS

Browse more resource reports ≫
Browse more technology reports ≫
Browse more life science reports ≫

BROWSE COMPANIES BY SECTOR

×